Señales en vivo de LUNG | Maximiza tus Ganancias con Getagraph.com

VENDER 115662 min ago

@ $14.55

Emitido: 14 feb 2024 @ 09:30

Retorno: -32.51%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: 2.50 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	705 914
Volumen promedio	611 808
Capitalización de mercado	378.44M
EPS	$0 ( 2024-02-21 )
Próxima fecha de ganancias	( $-0.430 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.14
ATR14	$0.0140 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Rose Geoffrey Beran	Sell	1 184	Common Stock
2024-04-03	Joshi Mehul	Buy	0
2024-03-22	Rose Geoffrey Beran	Sell	1 184	Common Stock
2024-03-15	Williamson Steven S.	Buy	425 116	Employee Stock Option (right to buy)
2024-03-15	Williamson Steven S.	Buy	205 286	Common Stock

INSIDER POWER
77.50
Last 98 transactions
Buy: 1 710 475 \| Sell: 224 988

Volumen Correlación

Largo: 0.39 (neutral)

Corto: 0.21 (neutral)

Signal:(66.486) Neutral

Pulmonx Corporation Correlación

10 Correlaciones Más Positivas
DBX	0.952
AKAM	0.944
MFIN	0.932
RAPT	0.927
HILS	0.92
BNIXU	0.919
PEAR	0.918
BRQS	0.917
QDEL	0.915
SMSI	0.914

10 Correlaciones Más Negativas
BWC	-0.959
ICON	-0.952
LMNL	-0.948
TWNK	-0.944
SCR	-0.941
IINN	-0.936
PAE	-0.928
FANG	-0.927
NXGN	-0.926
SCPL	-0.926

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pulmonx Corporation Correlación - Moneda/Commodity

-0.13
( neutral )

-0.20
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.24
( neutral )

-0.24
( neutral )

Pulmonx Corporation Finanzas

Annual	2023
Ingresos:	$68.68M
Beneficio Bruto:	$50.35M (73.32 %)
EPS:	$-1.600

FY	2023
Ingresos:	$68.68M
Beneficio Bruto:	$50.35M (73.32 %)
EPS:	$-1.600

FY	2022
Ingresos:	$53.66M
Beneficio Bruto:	$39.87M (74.29 %)
EPS:	$-1.590

FY	2021
Ingresos:	$48.42M
Beneficio Bruto:	$35.63M (73.59 %)
EPS:	$-1.350

Financial Reports:

No articles found.

Pulmonx Corporation

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Actualizaciones en tiempo real para Pulmonx Corporation [LUNG]

Upcoming Earnings Alert